CTTH - CTT Pharma Announces Mexico Patent Officially Granted
(TheNewswire)
Tampa, Florida, United States – TheNewswire – May31, 2022 – CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has expandedits reach into additional international markets with a successfulpatent application of its Oral Strip drug delivery system in Mexico.This allowed patent covers our “Oral Strip” delivery system, whichutilizes micelles to deliver accurate and reliable active ingredientdosages rapidly. The application of micelles in drug delivery is apowerful alternative for dissolving hydrophobic drugs in aqueousenvironments, minimizing drug degradation and loss, preventing harmfulside effects, and increasing drug bioavailability. This patent isideal for various medical APIs, including nicotine, CBD, CBG, CBN,caffeine and many other actives for the market in Mexico. Byincreasing our geographic footprint, CTT Pharma continues to pursueits strategy of monetizing its IP through partnerships for its drugdelivery technology in many of the world’s most rapidly growingmarkets.
“Our smoke-free alternative creates an opportunityfor CTT and futures partners in Mexico, as our technology gives us adistinct advantage in the delivery of Nicotine, CBD, CBN, CBG and manyother actives. Our strips dissolve in your mouth and enters thebloodstream bypassing the lungs and digestive tract, including theliver,” said Ryan Khouri, CEO of CTT Pharma.
CTT Pharma specializes in advanced drug delivery thathas patents granted and pending throughout the world. CTT successfullyreceived Health Canada approval for THC Strips and successfully soldout in several weeks to only 85,000 medical patients online with noadvertising. CTT will continue to keep shareholders updated onpatents, partnerships, and further corporate developments.
Contact Ryan Khouri at 813-606-0060
Copyright (c) 2022 TheNewswire - All rights reserved.